Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1830

1.

Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.

Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J.

J Antimicrob Chemother. 2009 Jun;63(6):1135-41. doi: 10.1093/jac/dkp122. Epub 2009 Apr 7.

PMID:
19351692
2.

Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.

Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP.

J Antimicrob Chemother. 2008 Aug;62(2):284-8. doi: 10.1093/jac/dkn181. Epub 2008 May 2.

PMID:
18453527
3.

Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.

Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S.

J Antimicrob Chemother. 2010 Apr;65(4):651-60. doi: 10.1093/jac/dkq004. Epub 2010 Jan 29.

PMID:
20118165
4.

Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain.

Mora A, Blanco M, López C, Mamani R, Blanco JE, Alonso MP, García-Garrote F, Dahbi G, Herrera A, Fernández A, Fernández B, Agulla A, Bou G, Blanco J.

Int J Antimicrob Agents. 2011 Jan;37(1):16-21. doi: 10.1016/j.ijantimicag.2010.09.012. Epub 2010 Nov 13.

PMID:
21075606
5.

Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.

Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH; Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN)..

J Antimicrob Chemother. 2010 Mar;65(3):465-9. doi: 10.1093/jac/dkp471. Epub 2010 Jan 6.

PMID:
20053690
6.

CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.

Oteo J, Orden B, Bautista V, Cuevas O, Arroyo M, Martínez-Ruiz R, Pérez-Vázquez M, Alcaraz M, García-Cobos S, Campos J.

J Antimicrob Chemother. 2009 Oct;64(4):712-7. doi: 10.1093/jac/dkp288. Epub 2009 Aug 11.

PMID:
19671590
7.

Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.

Peirano G, Costello M, Pitout JD.

Int J Antimicrob Agents. 2010 Jul;36(1):19-23. doi: 10.1016/j.ijantimicag.2010.02.016. Epub 2010 Mar 31.

PMID:
20359869
8.

Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2.

Oteo J, Diestra K, Juan C, Bautista V, Novais A, Pérez-Vázquez M, Moyá B, Miró E, Coque TM, Oliver A, Cantón R, Navarro F, Campos J; Spanish Network in Infectious Pathology Project (REIPI)..

Int J Antimicrob Agents. 2009 Aug;34(2):173-6. doi: 10.1016/j.ijantimicag.2009.03.006. Epub 2009 May 22. Erratum in: Int J Antimicrob Agents. 2010 Nov;36(5):483.

PMID:
19464856
9.

Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.

Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppé E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E.

J Antimicrob Chemother. 2009 Aug;64(2):274-7. doi: 10.1093/jac/dkp194. Epub 2009 May 27.

PMID:
19474064
10.

Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain).

Coelho A, Mora A, Mamani R, López C, González-López JJ, Larrosa MN, Quintero-Zarate JN, Dahbi G, Herrera A, Blanco JE, Blanco M, Alonso MP, Prats G, Blanco J.

J Antimicrob Chemother. 2011 Mar;66(3):517-26. doi: 10.1093/jac/dkq491. Epub 2010 Dec 21.

PMID:
21177675
11.

Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study.

Díaz MA, Hernández-Bello JR, Rodríguez-Baño J, Martínez-Martínez L, Calvo J, Blanco J, Pascual A; Spanish Group for Nosocomial Infections (GEIH)..

J Clin Microbiol. 2010 Aug;48(8):2840-5. doi: 10.1128/JCM.02147-09. Epub 2010 Jun 2.

12.

National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.

Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Blanco JE, Alonso MP, García-Garrote F, Chaves F, Orellana MÁ, Martínez-Martínez L, Calvo J, Prats G, Larrosa MN, González-López JJ, López-Cerero L, Rodríguez-Baño J, Pascual A.

J Antimicrob Chemother. 2011 Sep;66(9):2011-21. doi: 10.1093/jac/dkr235. Epub 2011 Jun 13.

PMID:
21669946
13.

Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases.

Dahbi G, Mora A, López C, Alonso MP, Mamani R, Marzoa J, Coira A, García-Garrote F, Pita JM, Velasco D, Herrera A, Viso S, Blanco JE, Blanco M, Blanco J.

Int J Antimicrob Agents. 2013 Oct;42(4):347-51. doi: 10.1016/j.ijantimicag.2013.06.017. Epub 2013 Aug 29.

PMID:
23992646
14.

Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.

Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH.

J Clin Microbiol. 2008 Dec;46(12):3900-5. doi: 10.1128/JCM.00734-08. Epub 2008 Oct 8.

15.

Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway.

Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, Sundsfjord A; Norwegian ESBL Study Group..

APMIS. 2009 Jul;117(7):526-36. doi: 10.1111/j.1600-0463.2009.02465.x.

PMID:
19594493
16.

Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.

Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, Takakura S, Ichiyama S; Kyoto-Shiga Clinical Microbiology Study Group..

J Antimicrob Chemother. 2012 Nov;67(11):2612-20. doi: 10.1093/jac/dks278. Epub 2012 Jul 26.

PMID:
22843833
17.

CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents.

Dolejska M, Frolkova P, Florek M, Jamborova I, Purgertova M, Kutilova I, Cizek A, Guenther S, Literak I.

J Antimicrob Chemother. 2011 Dec;66(12):2784-90. doi: 10.1093/jac/dkr363. Epub 2011 Sep 27.

PMID:
21954457
18.

Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.

Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, Arakawa Y.

J Antimicrob Chemother. 2009 Jan;63(1):72-9. doi: 10.1093/jac/dkn463. Epub 2008 Nov 11.

PMID:
19004839
19.
20.

Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.

Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J; Spanish Group for Nosocomial Infections (GEIH)..

J Clin Microbiol. 2013 Oct;51(10):3358-67. doi: 10.1128/JCM.01555-13. Epub 2013 Aug 7.

Supplemental Content

Support Center